NP 078585

Known as: NP-078585, NP078585 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2008-2012
0120082012

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
We previously reported the small organic N-type calcium channel blocker NP078585 that while efficacious in animal models for pain… (More)
  • figure 1
  • figure 2
  • table 2
  • table 7
  • table 6
Is this relevant?
Review
2010
Review
2010
Clinical exploitation of the therapeutic potential of calcium channels has long been limited to L-type blockers for… (More)
Is this relevant?
2009
2009
The therapeutic agents flunarizine and lomerizine exhibit inhibitory activities against a variety of ion channels and… (More)
  • figure 1
  • table 3
  • table 1
  • table 2
  • table 4
Is this relevant?
2009
2009
Dopamine (DA) efflux from terminals of the mesocorticolimbic system is linked to incentive motivation, drug dependency and… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2009
2009
We recently validated the N-type calcium channel as a target for the treatment of alcoholism and anxiety. N-type calcium channels… (More)
Is this relevant?
2008
2008
There is a clear need for new therapeutics to treat alcoholism. Here, we test our hypothesis that selective inhibitors of… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?